A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma.
Clin Transl Med
; 14(7): e1743, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39039937
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Antigens, CD20
/
Antigens, CD19
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Clin Transl Med
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States